A study of New York’s court-ordered care for people with serious mental health conditions adds to the research on this type ...

Kennedy and Oz say Medicaid isn't being cut. But state Medicaid directors say new policies are likely to cause many people to ...

Eli Lilly confirmed that it will allow more patients to apply for early access to retatrutide, an unapproved obesity drug ...

It is no longer possible to ask the FDA to keep pace with software development by doing the same reviews faster,” writes Dana ...

Medicare is removing flexibilities that have allowed "breakthrough" medical devices to leapfrog qualifications for extra ...

Two people have died in the cyclospora outbreak in Michigan in the first confirmed deaths in the U.S. related to the ...

Six weeks after STAT reported that Eli Lilly granted a single 79-year-old patient special access to retatrutide, an ...

Today, controversy over a regulator’s decision on AI scribes. Plus, a little more detail on Dexcom’s FDA pilot and an enlightening look at how scribes are working their way into medical education.

The California Supreme Court sided with Gilead Sciences in a closely watched case over whether the company had a "duty" to ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

AstraZeneca stock fell as investors balked at reports of merger talks with Bristol Myers Squibb about forming one of ​the ...

Medicaid work requirements in effect in Nebraska, AI scribes in med school, and more health news from Morning Rounds ...